THL-backed Red Nucleus completed the acquisition of COEUS.

THL-backed Red Nucleus, a range of products and services in the life sciences industry, completed the acquisition of COEUS, an innovative solutions for the healthcare industry, offering services in consulting, communications, technology, and talent. Financial term were not disclosed. “Our core mission is to support the world’s leading life science companies bring critical new therapies to market, helping the patients who need them most,” Mike Menta, Red Nucleus CEO.